Hikma Pharmaceutical | HIK - Market Capitalization

Stock Price
1,440.00
Daily Change
16.00 1.12%
Monthly
4.42%
Yearly
-30.37%
Q2 Forecast
1,414.37

Hikma Pharmaceutical reported $3.18B in Market Capitalization this May of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Almirall EUR 2.51B 251.72M May/2026
argenx SE USD 39.98B 4.4B May/2026
AstraZeneca USD 301.25B 13.1B Mar/2026
Autolus Therapeutics Ltd USD 529.63M 0 May/2026
Bayer EUR 37.69B 1.01B May/2026
Fresenius EUR 22.59B 5B May/2026
Genmab DKK 20.48B 1.02B Dec/2025
GlaxoSmithKline GBP 83.8B 9.44B Mar/2026
GRIFOLS EUR 3.69B 1.9B May/2026
Hikma Pharmaceutical USD 4.63B 1.42B Dec/2025
Lakefront Biotherapeutics EUR 1.58B 147.61M May/2026
Lonza CHF 39.68B 980.61M Jun/2025
Merck EUR 52.48B 826.08M May/2026
Orion EUR 9.83B 890.75M Mar/2026
Recordati EUR 10.41B 261.71M May/2026
Roche Holding CHF 266.34B 55.46B Dec/2025
Sanofi EUR 100.27B 605.48M Mar/2026
UCB EUR 46.41B 13.94B Dec/2025